Insulin medicines: Bill of materials
About these figures
Which unit, study and year the composition figures describe, and how they vary
No source opened gives the make-up of a vial or pen in grams. The active ingredient is a peptide made by microbes [6]. The medicine is sold as a solution or suspension in vials and cartridges [7] or in plastic pre-filled pens with glass inside [16]; no source opened lists the other ingredients. The pen body and the glass container are not yet product nodes. Stages are named only; no process conditions, strains or recipes are given.
as of 2026-11-13
Direct materials
The commodities and chemicals in one unit as bought, with amount, mass share, cost share and recycled content
| Material | Role | Amount in one unit | Share of the unit's mass |
|---|---|---|---|
| Pep Peptides and oligonucleotides | Functional | Not given | – |
| The active ingredient, insulin, is a peptide made recombinantly by microbes [6]; no source opened gives the mass per vial or pen. | |||
as of 2026-11-13
How it is put together
The main steps from parts and materials to the finished unit
| Step | What happens | Technology | Source |
|---|---|---|---|
| Recombinant production | Yeast, or E. coli in the bacterial route, carrying the human gene make an insulin precursor | Recombinant DNA (genetic engineering) | [6] |
| Conversion | An enzyme turns the precursor into human insulin; the E. coli route has an extra refolding stage | – | [6] |
| Chemical modification | For some analogues a fatty acid is attached to the insulin | – | [6] |
| Formulation and filling | The insulin is formulated and filled into cartridges and pre-filled pens, or into vials | – | [17][7] |
as of 2026-11-13
Technologies used to make it
The technologies used to make it, at which step
Made with- rDNA Recombinant DNA (genetic engineering) Recombinant production of the insulin precursor Humulin, approved by the FDA in 1982, was made by bacteria and was the first FDA-approved recombinant drug of any kind [3]; no share of output made this way was found.
as of 2026-11-13
Sources
- Insulin Development and Commercialization American Chemical Society (National Historic Chemical Landmark), 2023, landmark booklet, © 2023 American Chemical Society
- Insulin: Recombinant Production, Sustainability, and Chemistry Oxford Global (article by Tom Cohen on a presentation by Thomas Høeg-Jensen, Scientific Director at Novo Nordisk), 2023, page of 25 April 2023
- First human insulins prequalified World Health Organization, Prequalification of Medical Products, 2022, news item of 28 September 2022
- Patients return 200,000 injection pens through recycling scheme The Pharmaceutical Journal (David Lipanovic), 2023, article of 15 August 2023
- Novo Nordisk Opens New Insulin Formulation and Filling Facility in Russia CPHI Online, 2015, news item of 16 April 2015